Back to Markets
OROric Pharmaceuticals Inc

Oric Pharmaceuticals Inc

ORICNASDAQ NMS - GLOBAL MARKET
Health CareBiotechnology

$8.45

+0.000000 (+0.00%)

As of 05/29/26 EDT · USD

Compare
Low: $7.23Current: $8.45High: $14.93

Key Statistics

Open

$8.39

Day High

$8.83

Day Low

$8.31

Prev. Close

$8.45

VolumeShares traded today.

3.93M

Avg. VolumeAverage daily volume.

Market CapTotal value of all shares = price × shares outstanding.

$874.72M

P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.

-5.91

Forward P/EP/E based on forecast next-year earnings.

P/B RatioPrice-to-Book: share price ÷ book value per share.

52W HighHighest price over the past 52 weeks.

$14.93

52W LowLowest price over the past 52 weeks.

$7.23

50D MAAverage closing price over the last 50 trading days.

$9.75

200D MAAverage closing price over the last 200 trading days.

$10.83

Dividend YieldAnnual dividend ÷ share price, as a %.

BetaVolatility vs the market. >1 = more volatile than the S&P 500.

Performance

1W

-0.1%

1M

-10.5%

6M

-27.3%

YTD

+3.4%

1Y

-0.2%

About

Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

oricpharma.com/

Company Facts

SectorHealth Care
IndustryBiotechnology
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD

Sentiment

Latest News

Social Noise

Price Alerts

Loading…

Trade ORIC

Brokers available in your region (US)

Affiliate links — we may earn a commission. CFDs are risky.